tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market

BioMark Diagnostics (BUX) Income Statement

Compare
3 Followers

BioMark Diagnostics Income Statement

Last quarter (Q2 2024), BioMark Diagnostics's total revenue was C$38.35K, a decrease of -8.97% from the same quarter last year. In Q2, BioMark Diagnostics's net income was C$-547.31K. See BioMark Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
C$ 163.22KC$ 153.49KC$ 43.93KC$ 0.00C$ 263.28K
Gross Profit
C$ 163.22KC$ -232.70KC$ 43.93KC$ -13.69KC$ 263.28K
Operating Expenses
C$ 1.48MC$ 1.89MC$ 1.45MC$ 1.08MC$ 1.47M
Depreciation and Amortization
C$ 393.17KC$ 386.20KC$ 179.62KC$ 13.69KC$ 11.91K
EBITDA
C$ -919.05KC$ -1.35MC$ -1.22MC$ -1.08MC$ -1.20M
Operating Income
C$ -1.32MC$ -1.84MC$ -1.28MC$ -1.09MC$ -1.18M
Other Income/Expenses
C$ -304.16KC$ -110.15KC$ -50.80KC$ -596.00C$ -8.63K
Pretax Income
C$ -1.62MC$ -1.84MC$ -1.45MC$ -1.09MC$ -1.22M
Net Income
C$ -1.43MC$ -1.84MC$ -1.45MC$ -1.09MC$ -1.22M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.02
Diluted EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.02
Weighted Average Shares Outstanding
85.24M 82.78M 72.31M 73.30M 71.30M
Weighted Average Shares Outstanding (Diluted)
85.24M 82.78M 72.31M 73.30M 71.30M
Currency in CAD

BioMark Diagnostics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis